BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1441566)

  • 1. [Anabolic steroids in athletes].
    Yesalis CE; Wright JE; Lombardo JA
    Wien Med Wochenschr; 1992; 142(14):298-308. PubMed ID: 1441566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Popular ergogenic drugs and supplements in young athletes.
    Calfee R; Fadale P
    Pediatrics; 2006 Mar; 117(3):e577-89. PubMed ID: 16510635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anabolic steroids and sports].
    Kopera H
    Wien Med Wochenschr; 1986 Sep; 136(18):453-6. PubMed ID: 3798929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
    Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anabolic steroids in sport.
    VanHelder WP; Kofman E; Tremblay MS
    Can J Sport Sci; 1991 Dec; 16(4):248-57. PubMed ID: 1663826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anabolic steroids and their abuse in sports].
    Bruno M
    Clin Ter; 1990 Nov; 135(3):159-72. PubMed ID: 2150017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anabolics and sports].
    Horber FF
    Schweiz Med Wochenschr; 1990 Mar; 120(11):383-7. PubMed ID: 2320982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use and abuse of anabolic steroids in Olympic-caliber athletes.
    Bergman R; Leach RE
    Clin Orthop Relat Res; 1985 Sep; (198):169-72. PubMed ID: 4028547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of steroids for self-enhancement: an epidemiologic/societal perspective.
    Yesalis CE
    AIDS Read; 2001 Mar; 11(3):157-60. PubMed ID: 17004353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anesthesia for athletes using performance-enhancing drugs.
    Joyce JA
    AANA J; 1991 Apr; 59(2):139-44. PubMed ID: 2035296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abuse of drugs used to enhance athletic performance.
    Wagner JC
    Am J Hosp Pharm; 1989 Oct; 46(10):2059-67. PubMed ID: 2683762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS; Yesalis CE
    Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic steroids are fool's gold.
    Ryan AJ
    Fed Proc; 1981 Oct; 40(12):2682-8. PubMed ID: 6269903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance-enhancing substances in adolescent athletes.
    Gomez JE
    Tex Med; 2002 Feb; 98(2):41-6. PubMed ID: 11862891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention.
    Mulcahey MK; Schiller JR; Hulstyn MJ
    Phys Sportsmed; 2010 Oct; 38(3):105-13. PubMed ID: 20959703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic steroid abuse.
    Landry GL; Primos WA
    Adv Pediatr; 1990; 37():185-205. PubMed ID: 2264527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of anabolic steroids in athletes. A constant threat.
    Maravelias C; Dona A; Stefanidou M; Spiliopoulou C
    Toxicol Lett; 2005 Sep; 158(3):167-75. PubMed ID: 16005168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroids. Building a better you?
    Berlin B
    N J Med; 1999 Mar; 96(3):49-51. PubMed ID: 15038237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: insulin-like growth factor I and procollagen type III peptide.
    Abellan R; Ventura R; Pichini S; Di Giovannandrea R; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2006 Dec; 27(12):976-83. PubMed ID: 16612742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.